https://wiki.tiffa.net/w/index.php?action=history&feed=atom&title=Translations%3AHyperlipidemia%2F9%2Fen 2026-05-11T05:35:53Z Revision history for this page on the wiki MediaWiki 1.43.0 https://wiki.tiffa.net/w/index.php?title=Translations:Hyperlipidemia/9/en&diff=138695&oldid=prev 2024-04-13T08:18:34Z

<p>Importing a new version from external source</p> <p><b>New page</b></p><div>! Defect<br /> ! Increased lipoprotein<br /> ! Main symptoms<br /> ! Treatment<br /> ! Serum appearance<br /> ! Estimated prevalence<br /> |-<br /> !rowspan=3| [[Type I hyperlipoproteinemia|Type I]]<br /> ! [[Hyperlipoproteinemia type Ia|a]]<br /> | {{OMIM|238600||none}}<br /> | Buerger-Gruetz syndrome or familial hyperchylomicronemia<br /> | Decreased [[lipoprotein lipase]] (LPL)<br /> |rowspan=3| [[Chylomicrons]]<br /> |rowspan=3| [[Acute pancreatitis]], [[lipemia retinalis]], eruptive skin [[xanthoma]]s, [[hepatosplenomegaly]]<br /> |rowspan=3| Diet control<br /> |rowspan=3| Creamy top layer<br /> |rowspan=3| One in 1,000,000<br /> |-<br /> ! [[hyperlipoproteinemia type Ib|b]]<br /> | {{OMIM|207750||none}}<br /> | Familial apoprotein CII deficiency<br /> | Altered [[apolipoprotein C2|ApoC2]]<br /> |-<br /> ! [[Hyperlipoproteinemia type Ic|c]]<br /> | {{OMIM|118830||none}}<br /> |<br /> | [[Lipoprotein lipase|LPL]] inhibitor in blood<br /> |-<br /> !rowspan=2| Type II<br /> ! a<br /> | {{OMIM|143890||none}}<br /> | [[Familial hypercholesterolemia]]<br /> | [[LDL receptor]] deficiency<br /> | [[LDL]]<br /> | [[Xanthelasma]], [[arcus senilis]], tendon xanthomas<br /> | [[Bile acid sequestrant]]s, [[statin]]s, [[niacin (substance)|niacin]]<br /> | Clear<br /> | One in 500 for heterozygotes<br /> |-<br /> ! b<br /> | {{OMIM|144250||none}}<br /> | Familial combined hyperlipidemia<br /> | Decreased [[LDL receptor]] and increased [[apolipoprotein B|ApoB]]<br /> | [[LDL]] and [[VLDL]]<br /> |<br /> | Statins, niacin, [[fibrate]]<br /> | Turbid<br /> | One in 100<br /> |-<br /> !colspan=2| Type III<br /> | {{OMIM|107741||none}}<br /> | [[Familial dysbetalipoproteinemia]]<br /> | Defect in [[apolipoprotein E|Apo E 2]] synthesis<br /> | [[Intermediate density lipoprotein|IDL]]<br /> | Tuberoeruptive xanthomas and palmar xanthomas<br /> | Fibrate, statins<br /> | Turbid<br /> | One in 10,000<br /> |-<br /> !colspan=2| Type IV<br /> | {{OMIM|144600||none}}<br /> | [[Familial hypertriglyceridemia]]<br /> | Increased VLDL production and decreased elimination<br /> | VLDL<br /> |Can cause [[pancreatitis]] at high triglyceride levels<br /> | Fibrate, niacin, statins<br /> | Turbid<br /> | One in 100<br /> |-<br /> !colspan=2| [[#type V|Type V]]<br /> | {{OMIM|144650||none}}<br /> |<br /> | Increased VLDL production and decreased [[Lipoprotein lipase|LPL]]<br /> | VLDL and chylomicrons<br /> |<br /> | Niacin, fibrate<br /> | Creamy top layer and turbid bottom<br /> |<br /> |}</div>

FuzzyBot